IsoRay Story

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:3em;'>ISR</div>
A current spike in volatility has left many retail investors looking confused. In this story, we will sum up IsoRay Inc. Why are we still confident in our hopes for a recovery. On the 17th of September 2020 the company is traded for 0.71. IsoRay Inc stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.25%. The volatility of relative hype elasticity to IsoRay is about 4081.4%. Considering the 30-days investment horizon, the next forecasted announcement will be in a few days.
Published over a month ago
View all stories for IsoRay | View All Stories
Volatility may be your only friend when it comes to investing in IsoRay
We provide advice to complement the regular expert consensus on IsoRay. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time.
The successful prediction of IsoRay stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as IsoRay Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of IsoRay based on IsoRay hews, social hype, general headline patterns, and widely used predictive technical indicators. We also calculate exposure to IsoRay's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to IsoRay's related companies.

Use Technical Analysis to project IsoRay expected Price

IsoRay technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of IsoRay technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of IsoRay trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

How IsoRay utilizes its cash?

To perform a cash flow analysis of IsoRay, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash IsoRay is receiving and how much cash it distributes out in a given period. The IsoRay cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. IsoRay Net Cash Flow from Operations is relatively stable at the moment as compared to the past year. IsoRay reported last year Net Cash Flow from Operations of (3.64 Million)

Breaking down IsoRay Indicators

The latest bullish price patterns experienced by current IsoRay shareholders may raise some interest from retail investors. The stock closed today at a share price of 0.71 on slow start in trading volume. The company executives have been very successful in rebalancing the firm assets at opportune times to take advantage of market volatility in August. The stock standard deviation of daily returns for 30 days investing horizon is currently 3.51. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from IsoRay Inc partners.
 2017 2018 2019 2020 (projected)
Revenues USD5.92 M7.31 M8.41 M7.42 M
Revenues5.92 M7.31 M8.41 M7.42 M

Cost of Revenue Breakdown

IsoRay Cost of Revenue yearly trend continues to be relatively stable with very little volatility. Cost of Revenue is likely to drop to about 3.8 M. Cost of Revenue usually refers to the aggregate cost of goods produced and sold and services rendered during the reporting period. IsoRay Cost of Revenue is relatively stable at the moment as compared to the past year. IsoRay reported last year Cost of Revenue of 3.84 Million
20134.42 Million
20144.44 Million
20154.64 Million
20163.92 Million
20174.08 Million
20184.27 Million
20193.84 Million
20203.84 Million

Another 3 percent spike for IsoRay

The value at risk is down to -5.26 as of today. As of the 17th of September 2020, IsoRay retains the Downside Deviation of 3.1, market risk adjusted performance of (1.24), and Risk Adjusted Performance of 0.0257. IsoRay technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to analyze nineteen technical drivers for IsoRay Inc, which can be compared to its competitors. Please check out IsoRay Inc standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if IsoRay is priced fairly, providing market reflects its last-minute price of 0.71 per share. As IsoRay Inc is a penny stock we also advise to confirm its total risk alpha numbers.

Our Final Perspective on IsoRay

While some companies under the medical instruments & supplies industry are still a bit expensive, IsoRay may offer a potential longer-term growth to retail investors. All things considered, as of the 17th of September 2020, we believe that at this point, IsoRay is extremely dangerous with very small probability of financial unrest within the next 2 years. From a slightly different point of view, the entity appears to be undervalued. However, our actual 30 days advice on the enterprise is Strong Sell.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of IsoRay Inc. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to